Specialist Nurse-Led Intervention in Outpatients with Congestive Heart Failure: Impact on Clinical and Economic Outcomes

Disease Management and Health Outcomes

Volumn 11, Issue 11, 2003, Pages 693-698

  Palmer, Nicholas D ^a   Appleton, Barbara ^b   Rodrigues, Erwin A ^b  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE; SPIRONOLACTONE;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MORTALITY; NURSE PRACTITIONER; OUTPATIENT CARE; PATHOPHYSIOLOGY; PATIENT EDUCATION; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; REVIEW; UNITED KINGDOM;

EID: 0242298147     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200311110-00001     Document Type: Review

References (52)

1. Ho KK, Anderson KM, Levy D, et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-15
2. Royal College of General Practitioners, Office of Population Census and Surveys, and the Department of Health and Social Security. Morbidity statistics from general practice: fourth national study, 1991-2. London: HMSO, 1998
3. Sanderson S. ACE Inhibitors in the treatment of chronic heart failure: effective and cost-effective. Bandolier 1994: 1 (8): 14-7
4. Cowie MR, Wood DA, Coats AJ, et al. Incidence and aetiology of heart failure: a population-based study. Eur Heart J 1999; 20: 421-8
5. SOLVD investigators. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302
6. Acute Infarction Ramipril Efficacy (AIRE) Investigators. Effects of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 324: 821-8
7. MERIT Investigators. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (Merit-HF). Lancet 1998; 353: 201-7
8. Murdoch DR, Love MP, McMurray JJV, et al. Importance of heart failure as a cause of death: changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992. Eur Heart J 1998; 19: 1829-35
9. Murray J, Hart W, Rhodes G. An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Med Econ 1993; 6: 91-8
10. Haldeman GA, Croft JB, Giles WH, et al. Hospitalisation of patients with heart failure: national hospital discharge survey 1985-1995. Am Heart J 1999; 137: 3520-60
11. McMurray J, McDonagh T, Morrison CE, et al. Trends in hospitalisation for heart failure in Scotland 1980-1990. Eur Heart J 1993; 14: 1158-62
12. McMurray J, Petrie MC, Murdoch DR, et al. Clinical epidemiology of heart failure: public and private health burden. Eur Heart J 1998; 19: 9-16
13. Appleton B, Palmer ND, Rodrigues EA. Study to evaluate specialist nurse-led intervention in an outpatient population with stable congestive heart failure: results of a prospective, randomised study (the SENIF trial) [abstract]. J Am Coll Cardiol 2002; 39 (9): 33B
14. Randomised Aldactone Evaluation Study (RALES) investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-17
15. Digitalis Investigation Group (DIG). The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33
16. Northridge DB. Nitrates in heart failure. BMJ 1996; 12: 352-6
17. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-35
18. Vinson JM, Rich MW, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990; 38: 1290-5
19. Opasich C, Febo O, Riccardi G, et al. Concomitant factors of decompensation in chronic heart failure. Am J Cardiol 1996; 78: 354-7
20. Chin MH, Goldman L. Factors contributing to the hospitalisation of patients with congestive heart failure. Am J Public Health 1997; 87: 643-8
21. Gooding J, Jette AM. Hospital readmissions among the elderly. J Am Geriatr Soc 1985; 33: 595-601
22. Andrews K. Relevance of readmission of elderly patients discharged from a geriatric unit. J Am Geriatr Soc 1986; 34: 15-21
23. Michalsen A, Konig G, Thimme W. Preventable causative factors leading to hospital admissions with decompensated heart failure. Heart 1998; 80: 437-41
24. Reis SE, Holubkov R, Feldman AM, et al. Treatment of patients admitted to the hospital with congestive heart failure: speciality-related disparities in practice pattern and outcomes. J Am Coll Cardiol 1997; 30: 733-8
25. Stevenson LW. Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics. J Heart Lung Transplant 1991; 10: 468-76
26. Cleland JGF. Health economic consequences of pharmacological treatment of heart failure. Eur Heart J 1998; 19 Suppl. P: 32-9
27. McMurray JJV. Failure to practice medicine based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors? Eur Heart J 1999; 20 Suppl.: 15-22
28. Davidson F, Haghfelt T, Gram LF. Adverse drug reactions and drug compliance as primary cause of admission to a cardiology department. Eur J Clin Pharm 1988; 34: 83-6
29. Monane M, Bohn RL, Gurwitz JH, et al. Non-compliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994; 154: 433-7
30. Victor CR, Vetter NJ. The early admission of the elderly to the hospital. Age Ageing 1985; 14: 37-42
31. Williams EL, Fitton F. Factors effecting early unplanned readmissions of elderly patients to hospital. BMJ 1988; 297: 784-7
32. Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995; 16: 741-51
33. Department of Health. The National Service Framework for Coronary Heart Disease. London: Department of Health, 2000
34. Smith LE, Fabbri SA, Pai R, et al. Symptomatic improvement and reduced hospitalisation for patients attending a cardiomyopathy clinic. Clin Cardiol 1997; 20: 949-54
35. Abraham WT, Bristow MR. Specialist centre for heart failure management. Circulation 1997; 6: 2755-7
36. Houghton AR, Cowley AJ. Managing heart failure in a specialist clinic. J R Coll Physicians Lond 1997; 31 (3): 276-9
37. West JA, Miller NH, Parker KM, et al. A Comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilisation. Am J Cardiol 1997; 79: 58-63
38. Kegel LM. Advanced practice nurses can refine the management of heart management failure. Clin Nurse Spec 1995; 9 (2): 76-81
39. Hansen FR, Spedtsberg K, Schroll M, et al. Geriatric follow-up by home visits after discharge from hospital: a randomised controlled trial. Age Ageing 1992; 21: 445-50
40. Naylor MD, Brooten D, Campbell R. Comprehensive discharge planning and home follow-up of hospitalised elders: a randomised clinical trial. JAMA 1999; 281: 613-20
41. Weinberger M, Oddone EZ, Henderson WG, et al. Does increased access to primary care reduce hospital readmissions? N Engl J Med 1996; 334: 1441-7
42. Rich MW, Beckham V, Carney RM, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190-5
43. Stewart S, Pearson S, Horowitz JD, et al. Effects of home-based intervention on unplanned readmissions and out-of-hospital deaths. J Am Geriatr Soc 1998; 46: 74-80
44. Cline CMJ, Israelsson BYA, Erhardt LR, et al. Cost effective management programme for heart failure reduces hospitalisation. Heart 1998; 80: 442-6
45. Townsend J, Piper M, Frank AO, et al. Reduction in hospital readmission stay of elderly patients by a community based hospital discharge scheme: a randomised controlled trial. BMJ 1998; 297: 20-7
46. Blue L, Lang E, Morrison CE, et al. Randomised controlled trial of specialist-led intervention in heart failure. BMJ 2001; 323 (7315): 715-8
47. Cofer LA. Aggressive cholesterol management: role of the lipid nurse specialist. Heart Lung 1997; 26 (5): 337-44
48. Taylor CB, Debrusk R. Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention. Ann Intern Med 1990; 113: 118-23
49. Perry HM, Sambhi MP, Cusham WC, et al. The VA hypertension and screening programme. Nurse Pract 1992; 11: 54-60
50. Peters AL, Davidson MB, Ossorio CR. Management of patients with diabetes by nurse with support of sub-specialists. Arch Intern Med 1995; 9: 8-12
51. Fonarow GC, Stevenson LW, Woo MA, et al. Impact of a comprehensive heart failure management programme on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997; 30: 725-32
52. Topp R, Tucker D, Weber C. Effect of a clinical case manager/clinical nurse specialist on patient hospitalised with congestive heart failure. Nurs Case Manag 1998; 3: 140-7